Items where Author is "<span class="person_name">Gorog, Diana</span>"
Number of items: 72.
Article
Antithrombotic management during percutaneous mechanical circulatory support - defining the status quo, before agreeing quo vadis. (2024)
Diana Gorog
and
Alain Combes
![]()
Tissue factor pathway inhibitor and interleukin-1 receptor levels in COVID-19. (2024)
Diana Gorog
and
Brijesh Patel
![]()
Impact of Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy on Endogenous Fibrinolysis in Acute Coronary Syndrome: The VaLiDate-R study. (2024)
Ying X. Gue,
Vassilios Memtsas,
Rahim Kanji,
David Wellsted,
Amanda Busby,
Megan Smith,
Enric Vilar,
Alisdair Ryding,
Deepa J. Arachchillage
and
Diana Gorog
![]()
Global Thrombosis Test: Occlusion Is Attributable to Shear-Induced Platelet Thrombus Formation. (2023)
Diana Gorog
and
Junichiro Yamamoto
![]()
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events Comparing East Asians With Westerners: A Meta-Analysis. (2023)
Rock Bum Kim,
Ang Li,
Ki-Soo Park,
Yune-Sik Kang,
Jang-Rak Kim,
Eliano P Navarese,
Diana Gorog,
Udaya S. Tantry,
Paul A Gurbel,
Jin-Yong Hwang,
Oh-Young Kwon
and
Young-Hoon Jeong
![]()
P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study. (2023)
Seung-Yul Lee,
Young-Hoon Jeong,
Kyeong Ho Yun,
Jae Young Cho,
Diana Gorog,
Dominick J. Angiolillo,
Kim Jin Won
and
Yangsoo Jang
![]()
Measuring thrombus stability at high shear, together with thrombus formation and endogenous fibrinolysis: first experience using the Global Thrombosis Test 3 (GTT-3). (2023)
Rahim Kanji,
Joshua Leader,
Vassilios Memtsas
and
Diana Gorog
![]()
Anticoagulation in the ICU: a future for contact pathway inhibition? (2023)
Charlotte J Van Edom,
Diana Gorog
and
Christophe Vandenbriele
![]()
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis. (2023)
Diana Gorog,
Jose Luis Ferreiro,
Ingo Ahrens,
Junya Ako,
Tobias Geisler,
Sigrun Halvorsen,
Kurt Huber,
Young-Hoon Jeong,
Eliano P Navarese,
Andrea Rubboli,
Dirk Sibbing,
Jolanta M Siller-Matula,
Robert F. Storey,
Jack W C Tan,
Jurrien M.ten Berg,
Marco Valgimigli,
Christophe Vandenbriele
and
Gregory Y H Lip
![]()
Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation. (2023)
Geoffrey D Barnes,
Walter Ageno,
Lana A Castellucci,
Thita Chiasakul,
Renee Eslick,
Jose Luis Ferreiro,
David Gailani,
Diana Gorog,
Gregory Y H Lip,
Leslie Raffini,
Suely M Rezende,
Jeffrey I Weitz
and
Adam Cuker
![]()
Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction. (2023)
Rahim Kanji,
Ying X. Gue,
Vassilios Memtsas,
Neil H. Spencer
and
Diana Gorog
![]()
Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction. (2023)
Seung Hun Lee,
Hyun Kuk Kim,
Jong-Hwa Ahn,
Min Gyu Kang,
Kye-Hwan Kim,
Jae Seok Bae,
Sang Young Cho,
Jin-Sin Koh,
Yongwhi Park,
Seok Jae Hwang,
Diana Gorog,
Udaya S. Tantry,
Kevin P. Bliden,
Paul A Gurbel,
Jin-Yong Hwang
and
Young-Hoon Jeong
![]()
Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis. (2023)
Diana Gorog,
Visvesh Jeyalan,
Rafaella I. L. Markides,
Eliano P Navarese,
Young-Hoon Jeong
and
Mohamed Farag
![]()
Effect of Remote Ischaemic Conditioning on the inflammatory cytokine cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial. (2022)
Kishal Lukhna,
Helison R. P. do Carmo,
Alejandro Rossell Castillo,
Sean M. Davidson,
Hayli Geffen,
Sara Giesz,
Pelin Golforoush,
Ticiane Gonçalez Bovi,
Diana Gorog,
Alan Salama,
Aqeela Imamdin,
Siavash Kalkhoran,
Sandrine Lecour,
Mauricio W. Perroud Jr.,
Mpiko Ntsekhe,
Andrei C. Sposito
and
Derek M. Yellon
![]()
Antithrombotic in atrial fibrillation and coronary artery disease – Does less mean more? (2022)
Ying X. Gue,
Diana Gorog
and
Gregory Y H Lip
![]()
Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with Atrial Fibrillation. (2022)
Jonathan P Piccini,
Valeria Caso,
Stuart J Connolly,
Keith A A Fox,
Jonas Oldgren,
Schuyler Jones,
Diana Gorog,
Vaclav Durdil,
Thomas Viethen,
Christoph Neumann,
Hardi Mundl
and
Manesh R Patel
![]()
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: An European and Asia-Pacific Expert Consensus Paper. (2022)
Diana Gorog,
Ying X. Gue,
Tze-Fan Chao,
Laurent Fauchier,
Jose Luis Ferreiro,
Kurt Huber,
Stavros V Konstantinidis,
Deirdre A Lane,
Francisco Marin,
Jonas Oldgren,
Tatjana Potpara,
Vanessa Roldan,
Andrea Rubboli,
Dirk Sibbing,
Hung-Fat Tse,
Gemma Vilahur
and
Gregory Y H Lip
![]()
NETs in the infarct-related coronary artery – a marker or mediator of adverse outcome? (2022)
Diana Gorog
and
Steffen Massberg
![]()
Influence of Hypercoagulability and Impaired Fibrinolysis on Occurrence of Acute Myocardial Infarction and Prognostic Implication Following Percutaneous Coronary Intervention. (2021)
Hyun Kuk Kim,
Seung Hun Lee,
Jong-Hwa Ahn,
Min Gyu Kang,
Kye-Hwan Kim,
Jae Seok Bae,
Sang Young Cho,
Jin-Sin Koh,
Yongwhi Park,
Seok Jae Hwang,
Diana Gorog,
Udaya S. Tantry,
Paul A Gurbel,
Jin-Yong Hwang
and
Young-Hoon Jeong
![]()
When a meta-analysis equals a single large-scale trial with meaningful follow-up. (2021)
Eliano P Navarese,
Dean Kereiakes,
Diana Gorog,
Alexandra Lansky
and
Felicita Andreotti
![]()
Cardiovascular disease and COVID-19: a position paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). (2021)
Edino Cenko,
L Badimon,
Raffaele Bugiardini,
Marc Claeys,
Giuseppe de Luca,
Cor de Wit,
Geneviève Derumeaux,
Maria Dorobantu,
Dirk Duncker,
Etto Eringa,
Diana Gorog,
Christian Hassager,
Frank Heinzel,
Kurt Huber,
Olivia Manfrini,
Davor Milicic,
Evangelos Oikonomou,
Teresa Padro,
Danijela Trifunovic-Zamaklar,
Zorana Vasilejevic-Pokrajcic
and
Marija Vavlukis
![]()
Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention? (2021)
Diana Gorog,
Eliano P Navarese
and
Felicita Andreotti
![]()
Spontaneous reperfusion in patients with transient ST-elevation myocardial infarction - prevalence, importance and approaches to management. (2021)
Mohamed Farag,
Marta Peverelli,
Nikolaos Spinthakis,
Ying X. Gue,
Mohaned Egred
and
Diana Gorog
![]()
Incidence of thrombotic complications in COVID-19. (2021)
William Jenner
and
Diana Gorog
![]()
Screening for venos thromboembolism in patient with COVID-19. (2021)
Christophe Vandenbriele
and
Diana Gorog
![]()
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: A systematic review and meta-analysis. (2021)
Eliano P Navarese,
Alexandra Lansky,
Dean Kereiakes,
Jacek Kubica,
Paul A Gurbel,
Diana Gorog,
Marco Valgimigli,
Nick Curzen,
David. E. Kandzari,
Marc Bonaca,
Marc Brouwer,
Julia M Umińska,
Milosz Jaguszewski,
Paolo Raggi,
Ron Waksman,
Martin B. Leon,
William Wijns
and
Felicita Andreotti
![]()
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention. (2021)
Bhatt Deepak,
Juan Carlos Kaski,
Sean Delaney,
Mirvat Alasnag,
Felicita Andreotti,
Dominick J. Angiolillo,
Albert Ferro,
Diana Gorog,
Alberto Lorenzatti,
Mamas A. Mamas,
John McNeil,
José C Nicolau,
Gabriel Philippe Steg,
Juan Tamargo,
Tan Doreen
and
Marco Valgimigli
![]()
Optimal tests to minimise bleeding and ischaemic complications in patients on extracorporeal membrane oxygenation. (2021)
Rahim Kanji,
Christophe Vandenbriele,
Deepa R.J Arachchillage,
Susanna Price
and
Diana Gorog
![]()
Fibrinolysis in platelet thrombi. (2021)
Rahim Kanji,
Ying X. Gue,
Vassilios Memtsas
and
Diana Gorog
![]()
Assessment of endogenous fibrinolysis in clinical using novel tests - Ready for clinical roll-out? (2021)
Ying X. Gue,
Wern Yew Ding,
Gregory Y H Lip
and
Diana Gorog
![]()
Thrombotic complications in 2,928 patients with COVID-19 treated in intensive care: a systematic review. (2021)
William Jenner,
Rahim Kanji,
Saeed Mirsadraee,
Ying X. Gue,
Susanna Price,
Sanjay Prasad
and
Diana Gorog
![]()
Antithrombotic therapy in diabetes: Which, when, and for how long? (2021)
RA Ajjan,
N Kietsiriroje,
L Badimon,
Diana Gorog,
Dominick J. Angiolillo,
D Russel,
Bianca Rocca
and
Robert F. Storey
![]()
Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: A Pandora Box to Explain Prognostic Differences. (2021)
Hyun Kuk Kim,
Udaya S. Tantry,
Hyun-Woong Park,
Tobias Geisler,
Diana Gorog,
Paul A Gurbel
and
Young-Hoon Jeong
Non-Vitamin K Antagonist Oral Anticoagulants versus Warfarin for Patients with Left Ventricular Thrombus: A Systematic Review and Meta-analysis. (2021)
Ying X. Gue,
Nikolaos Spinthakis,
Mohaned Egred,
Diana Gorog
and
Mohamed Farag
![]()
Precision treatment in ACS – role of assessing fibrinolysis. (2021)
Ying X. Gue,
Young-Hoon Jeong,
Mohamed Farag,
Nikolaos Spinthakis
and
Diana Gorog
![]()
Role, laboratory assessment and clinical relevance of fibrin, factor XIII and endogenous fibrinolysis in arterial and venous thrombosis. (2021)
Vassilios Memtsas,
Deepa RJ Arachchillage
and
Diana Gorog
![]()
Prevalence of Thrombotic Complications in ICU-Treated Patients With Coronavirus Disease 2019 Detected With Systematic CT Scanning. (2021)
Saeed Mirsadraee,
Diana Gorog,
CF Mahon,
B Rawal,
TR Semple,
Ed Nicol,
Deepa RJ Arachchillage,
A Devaraj,
Price S,
SR Desai,
CA Ridge,
S Singh
and
SPG Padley
![]()
Endogenous fibrinolysis - relevance to clinical thrombosis risk assessment. (2020)
Rahim Kanji,
Jacek Kubica,
Eliano P Navarese
and
Diana Gorog
![]()
2-oxothiazolidine-4-carboxylic acid inhibits vascular calcification via induction of glutathione synthesis. (2020)
Jessal Patel,
Lucie E Bourne,
Shori Thakur,
Kenneth Farrington,
Diana Gorog,
Isabel R Orriss
and
Anwar Baydoun
![]()
Bioprosthetic valve thrombosis and degeneration following transcatheter aortic valve implantation (TAVI). (2020)
Saeed Mirsadraee
and
Diana Gorog
![]()
Low-grade endotoxemia and platelets: a deadly aggregation. (2020)
Luca Liberale
and
Diana Gorog
![]()
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome. (2020)
Wilbert Bor
and
Diana Gorog
![]()
Point-of-care Platelet Function Tests: Relevance to Arterial Thrombosis and Opportunities for Improvement. (2020)
Diana Gorog
and
Richard Becker
![]()
Angiotensin Converting Enzyme 2 may mediate disease severity in COVID-19. (2020)
Ying X. Gue,
Rahim Kanji
and
Diana Gorog
![]()
Peripartum cardiomyopathy- can the link between prolactin and PAI-1 provide a clue? (2020)
Diana Gorog
and
Gemma Vilahur
![]()
Usefulness of the NULL-PLEASE Score to predict 1 survival in out-of hospital cardiac arrest. (2020)
Ying Gue,
Max Sayers,
Benjamin Whitby,
Rahim Kanji,
Krishma Adatia,
Robert Smith,
William Davies,
Aris Perperoglou,
Tatjana Potpara,
Gregory Y H Lip
and
Diana Gorog
![]()
MINOCA presenting with STEMI- a review of incidence, aetiology, assessment and treatment. (2020)
Ying X. Gue,
Rahim Kanji,
Sabiha Gati
and
Diana Gorog
![]()
Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction- a substudy of the CONDI-2/ERIC4 PPCI randomised controlled trial. (2020)
Diana Gorog,
Mohamed Farag,
Nikolaos Spinthakis,
Derek M. Yellon,
Hans E Bøtker†,
Rajesh Kharbanda
and
Derek Hausenloy
![]()
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2020)
Diana Gorog,
Susanna Price,
Dirk Sibbing,
Andreas Baumbach,
Davide Capodanno,
Bruna Gigante,
Sigrun Halvorsen,
Kurt Huber,
Maddalena Lettino,
Sergio Leonardi,
Joao Morais,
Andrea Rubboli,
Jolanta M Siller-Matula,
Robert F. Storey,
Pascal Vranckx
and
Bianca Rocca
![]()
Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention : A Meta-Analysis. (2020)
Ying Gue,
Nikolaos Spinthakis,
Mohamed Farag,
Jacek Kubica,
Jolanta M Siller-Matula,
Manivannan Srinivasan
and
Diana Gorog
![]()
Platelet inhibition in acute coronary syndrome and PCI: Insights from the past and present. (2020)
Diana Gorog
and
Tobias Geisler
![]()
Fatal heart block from intentional yew tree (Taxus baccata) ingestion: a case report. (2019)
Natasha G,
Mark Chan,
Ying X. Gue
and
Diana Gorog
![]()
MINOCA presenting with STEMI – incidence, aetiology and outcome in a contemporaneous cohort. (2019)
Ying X. Gue,
Natasha Corballis,
Alisdair Ryding,
Juan Carlos Kaski
and
Diana Gorog
![]()
Relationship of platelet reactivity and inflammatory markers to recurrent adverse events in patients with ST-elevation myocardial infarction. (2019)
Krishma Adatia,
Mohamed Farag,
Ying X. Gue,
Manivannan Srinivasan
and
Diana Gorog
![]()
Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. (2019)
Derek Hausenloy,
Rajesh Kharbanda,
Ulla Kristine Møller,
Manish Ramlall,
Jens Aarøe,
Robert Butler,
Heerajnarain Bulluck,
Tim Clayton,
Ali Dana,
Matthew Dodd,
Thomas Engstrom,
Richard Evans,
Jens Flensted Lassen,
Erika Christensen,
José Manuel Garcia-Ruiz,
Diana Gorog,
Jakob Hjort,
Richard Houghton,
Borja Ibanez,
Rosemary Knight,
Freddy K Lippert,
Jacob Lønborg,
Michael Maeng,
Dejan Milasinovic,
Ranjit More,
Jennifer M Nicholas,
Lisette O Jensen,
Alexander Perkins,
Nebojsa Radovanovic,
Roby Rakhit,
Jan Ravkilde,
Alisdair D Ryding,
Michael R Schmidt,
Ingun S Riddervold,
Sørensen,
Goran Stankovic,
Madhusudhan Varma,
Ian Webb,
Christian J Terkelsen,
John Greenwood,
Derek Yellon
and
Hans E Bøtker†
![]()
Apixaban Enhances Endogenous Fibrinolysis in Patients with Atrial Fibrillation. (2019)
Nikolaos Spinthakis,
Ying X. Gue,
Mohamed Farag,
Manivannan Srinivasan,
David Wellsted,
Gregory Y H Lip,
Deepa RJ Arachchillage
and
Diana Gorog
![]()
Understanding the Effects of NOAC Combined with Antiplatelet Therapy on Clot Kinetics. (2019)
Diana Gorog
![]()
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice. (2019)
Tobias Geisler,
Rezo Jorbenadze,
Aron-Frederik Popov,
Karin L. Mueller,
Dominik Rath,
Michal Droppa,
Juergen Schreieck,
Peter Seizer,
Robert F. Storey,
Steen D. Kristensen,
Andrea Rubboli,
Diana Gorog,
Daniel Aradi,
Dirk Sibbing,
Kurt Huber,
Meinrad Gawaz
and
Jur Ten Berg
![]()
Metabolism of ticagrelor in patients with acute coronary syndromes. (2018)
Piotr Adamski,
Katarzyna Buszko,
Joanna Sikora,
Piotr Niezgoda,
Malwina Barańska,
Małgorzata Ostrowska,
Przemysław Paciorek,
Eliano P Navarese,
Diana Gorog
and
Jacek Kubica
![]()
Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications. (2018)
Diana Gorog
![]()
More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. (2018)
Nikolaos Spinthakis,
Mohamed Farag,
Bianca Rocca
and
Diana Gorog
![]()
Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice. (2018)
Kavitha Vimalesvaran,
Seth J Dockrill
and
Diana Gorog
![]()
PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease. (2014)
G. Rosser,
P. Tricoci,
D. Morrow,
C. Christopoulos,
M. Niespialowska-Steuden,
Robert Kozarski,
R. Wilcox
and
Diana Gorog
Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential. (2014)
Diana Gorog,
J. Yamamoto,
N. Inoue,
K. Otsui
and
H. Ishii
Novel oral anticoagulants in acute coronary syndrome. (2013)
C. Costopoulos,
M. Niespialowska-Steuden,
N. Kukreja
and
Diana Gorog
Novel antithrombotic agents for atrial fibrillation. (2012)
M.M. Niespialowska-Steuden,
Diana Gorog
and
V. Markides
Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction. (2010)
S. Saraf,
C. Christopoulos,
I.B. Salha,
D. Stott
and
Diana Gorog